List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 8424 studies with search of:   Open Studies | "Neoplasms"
  Display Options
Rank Status Study
1 Recruiting Cognitive and Behavioral Therapy or Standard Care in Patients With Advanced Gastrointestinal Cancer or Lung Cancer
Conditions: Cancer-Related Problem/Condition;   Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Lung Cancer;   Pancreatic Cancer
Interventions: Procedure: counseling;   Procedure: educational intervention;   Procedure: meditation therapy;   Procedure: psychosocial assessment and care;   Procedure: quality-of-life assessment;   Procedure: questionnaire administration;   Procedure: standard follow-up care
2 Recruiting ChemoFx® Observational Study in Gynecological Solid Tumors
Conditions: Ovarian Cancer;   Fallopian Tube Cancer;   Peritoneal Neoplasms;   Uterine Cancer;   Endometrial Cancer;   Vaginal Cancer;   Vulvar Cancer;   Cervical Cancer
Intervention:
3 Recruiting Biomarkers and Radiation Side Effects in Patients Undergoing Radiation Therapy for Gastrointestinal Cancer
Conditions: Cancer-Related Problem/Condition;   Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Liver Cancer;   Pancreatic Cancer
Interventions: Procedure: DNA methylation analysis;   Procedure: laboratory biomarker analysis;   Procedure: management of therapy complications;   Procedure: mutation analysis;   Procedure: observation;   Procedure: polymerase chain reaction
4 Recruiting Paclitaxel and Bortezomib in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors
Conditions: Breast Cancer;   Colorectal Cancer;   Head and Neck Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Pancreatic Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bortezomib;   Drug: paclitaxel;   Procedure: high performance liquid chromatography;   Procedure: immunohistochemistry staining method;   Procedure: laboratory biomarker analysis;   Procedure: pharmacological study;   Procedure: protein expression analysis;   Procedure: western blotting
5 Recruiting Printed Education Materials in Patients Who Are Finishing Treatment for Stage I, Stage II, or Stage IIIA Breast Cancer, Colorectal Cancer, Prostate Cancer, or Chest Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Colorectal Cancer;   Lung Cancer;   Malignant Mesothelioma;   Prostate Cancer;   Thymoma and Thymic Carcinoma
Intervention: Procedure: educational intervention
6 Recruiting High-Dose Chemotherapy With or Without Total-Body Irradiation Followed by Autologous Stem Cell Transplant in Treating Patients With Hematologic Cancer or Solid Tumors
Conditions: Childhood Germ Cell Tumor;   Leukemia;   Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm;   Neuroblastoma;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: busulfan;   Drug: carboplatin;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: etoposide;   Drug: melphalan;   Drug: thiotepa;   Procedure: total-body irradiation
7 Recruiting Study of Symptoms Caused by Cancer and Cancer Therapy in Patients With Invasive Breast, Lung, Prostate, or Colorectal Cancer
Conditions: Breast Cancer;   Cancer-Related Problem/Condition;   Colorectal Cancer;   Lung Cancer;   Pain;   Prostate Cancer
Interventions: Procedure: assessment of therapy complications;   Procedure: cognitive assessment;   Procedure: psychosocial assessment and care
8 Recruiting Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer
Conditions: Brain and Central Nervous System Tumors;   Intraocular Melanoma;   Lung Cancer;   Melanoma (Skin);   Metastatic Cancer;   Neuroblastoma;   Ovarian Cancer;   Retinoblastoma;   Sarcoma;   Small Intestine Cancer
Interventions: Drug: iodine I 131 monoclonal antibody 3F8;   Procedure: immunologic technique;   Procedure: pharmacological study
9 Recruiting Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer
Conditions: Anal Cancer;   Carcinoma of the Appendix;   Colorectal Cancer;   Esophageal Cancer;   Extrahepatic Bile Duct Cancer;   Gallbladder Cancer;   Gastric Cancer;   Gastrointestinal Carcinoid Tumor;   Gastrointestinal Stromal Tumor;   Liver Cancer;   Pancreatic Cancer;   Small Intestine Cancer
Interventions: Drug: fluorouracil;   Drug: irinotecan hydrochloride;   Drug: leucovorin calcium;   Procedure: pharmacogenomic studies;   Procedure: pharmacological study
10 Recruiting Study of DNA Mutations in Predicting the Effect of External-Beam Radiation Therapy in Patients With Early Breast Cancer, Localized Prostate Cancer, or Gynecological Cancer
Conditions: Breast Cancer;   Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Ovarian Cancer;   Prostate Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Interventions: Procedure: gene expression analysis;   Procedure: gene rearrangement analysis;   Procedure: laboratory biomarker analysis;   Procedure: polymorphism analysis;   Procedure: radiation therapy
11 Recruiting Nelfinavir in Treating Patients With Metastatic, Refractory, or Recurrent Solid Tumors
Conditions: Colorectal Cancer;   Gastrointestinal Carcinoid Tumor;   Head and Neck Cancer;   Islet Cell Tumor;   Lung Cancer;   Metastatic Cancer;   Neuroendocrine Carcinoma of the Skin;   Ovarian Cancer;   Pheochromocytoma;   Sarcoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: midazolam hydrochloride;   Drug: nelfinavir mesylate;   Procedure: gene expression analysis;   Procedure: immunoenzyme technique;   Procedure: immunologic technique;   Procedure: laboratory biomarker analysis;   Procedure: mass spectrometry;   Procedure: pharmacological study;   Procedure: polymerase chain reaction;   Procedure: protein expression analysis
12 Recruiting Questionnaire Study for Gynecological Cancer Survivors
Conditions: Endometrial Neoplasms;   Ovarian Neoplasms;   Uterine Cervical Neoplasms;   Vulvar Neoplasms;   Vaginal Neoplasms;   Genital Neoplasms, Female
Intervention: Behavioral: Psychosocial
13 Recruiting Busulfan, Melphalan, Topotecan, and a Stem Cell Transplant in Treating Patients With Newly Diagnosed or Relapsed Solid Tumor
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Kidney Cancer;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Testicular Germ Cell Tumor;   Unspecified Adult Solid Tumor, Protocol Specific;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: busulfan;   Drug: filgrastim;   Drug: melphalan;   Drug: topotecan hydrochloride;   Procedure: autologous bone marrow transplantation;   Procedure: autologous hematopoietic stem cell transplantation;   Procedure: pharmacological study
14 Recruiting Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Conditions: Cancer-Related Problem/Condition;   Cervical Cancer;   Endometrial Cancer;   Fallopian Tube Cancer;   Gestational Trophoblastic Tumor;   Ovarian Cancer;   Sarcoma;   Vaginal Cancer;   Vulvar Cancer
Intervention: Drug: fondaparinux sodium
15 Recruiting Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients With Cancer or Suspected Cancer
Conditions: Brain Neoplasms;   Lung Neoplasms;   Thyroid Neoplasms;   Colorectal Neoplasms;   Lymphoma
Intervention: Procedure: Positron Emission Tomography (PET) scan
16 Recruiting Electroacupuncture in Treating Delayed Nausea and Vomiting in Patients Receiving Chemotherapy For Newly Diagnosed Childhood Sarcoma, Neuroblastoma, Nasopharyngeal Cancer, Germ Cell Tumors, or Hodgkin Lymphoma
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Head and Neck Cancer;   Lymphoma;   Nausea and Vomiting;   Neuroblastoma;   Ovarian Cancer;   Sarcoma
Interventions: Procedure: electroacupuncture therapy;   Procedure: management of therapy complications;   Procedure: nausea and vomiting therapy
17 Recruiting Dasatinib and Bevacizumab in Treating Patients With Solid Tumors That Are Metastatic or Cannot be Removed by Surgery
Conditions: Breast Cancer;   Gastrointestinal Stromal Tumor;   Intraocular Melanoma;   Kidney Cancer;   Lung Cancer;   Melanoma (Skin);   Ovarian Cancer;   Prostate Cancer;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bevacizumab;   Drug: dasatinib
18 Recruiting Trabectedin in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment
Conditions: Brain and Central Nervous System Tumors;   Childhood Germ Cell Tumor;   Extragonadal Germ Cell Tumor;   Kidney Cancer;   Liver Cancer;   Neuroblastoma;   Ovarian Cancer;   Sarcoma;   Unspecified Childhood Solid Tumor, Protocol Specific
Interventions: Drug: filgrastim;   Drug: pegfilgrastim;   Drug: trabectedin
19 Recruiting Natural Killer Cells and Bortezomib to Treat Cancer
Conditions: Lung or Prostatic Neoplasms;   Colorectal or Kidney Neoplasms;   Pancreatic Neoplasms;   Leukemia, Myelogenous, Chronic, BCR-ABL Positive;   Melanoma
Intervention: Drug: NK cells +CliniMACs CD3 and CD56 systems
20 Not yet recruiting Disease Management Program or Usual Care in Patients With Stage III or Stage IV Lung Cancer, Pancreatic Cancer, Ovarian Cancer, or Colorectal Cancer, and Their Caregivers
Conditions: Colorectal Cancer;   Lung Cancer;   Ovarian Cancer;   Pancreatic Cancer
Interventions: Procedure: quality-of-life assessment;   Procedure: questionnaire administration

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options